Status: current, Defined. Date: 31-Mar 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2447341000168114 | Ursodox (LAPL) (ursodeoxycholic acid 250 mg) capsule, 60 capsules (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2447351000168111 | Ursodox (LAPL) 250 mg capsule, 60 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ursodox (LAPL) 250 mg capsule, 60 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Ursodox (LAPL) 250 mg capsule, 60 | Is a | ursodeoxycholic acid 250 mg capsule, 60 | true | Inferred relationship | Some | ||
| Ursodox (LAPL) 250 mg capsule, 60 | has TPUU | Ursodox (LAPL) 250 mg capsule | true | Inferred relationship | Some | 1 | |
| Ursodox (LAPL) 250 mg capsule, 60 | has TP | Ursodox (LAPL) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ursodox (LAPL) 250 mg capsule, 60, blister pack | Is a | True | Ursodox (LAPL) 250 mg capsule, 60 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR